Immunotherapy of acute myeloid leukemia: current approaches
/in Acute Leukemia, International Publications /von 2009-03-16 / Oncologist 2009 Mar;14(3):240-52Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium
/in Hyperthermia, International Publications /von 2009-03-11 / Cancer Chemother. Pharmacol. 2009 Nov;64(6):1079-83Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting
/in Dendritic Cells, International Publications /von 2009-03-11 / Blood 2009 May;113(21):5167-75Coordination of intratumoral immune reaction and human colorectal cancer recurrence
/in Colorectal Cancer, International Publications /von 2009-03-03 / Cancer Res. 2009 Mar;69(6):2685-93Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2009-03-01 / Expert Opin Biol Ther 2009 Mar;9(3):331-9Promising novel immunotherapies and combinations for prostate cancer
/in International Publications, Prostate Cancer /von 2009-03-01 / Future Oncol 2009 Mar;5(2):187-96
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution